These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 32112368)

  • 1. Urinary Exosomal MicroRNAs as Potential Non-invasive Biomarkers in Breast Cancer Detection.
    Hirschfeld M; Rücker G; Weiß D; Berner K; Ritter A; Jäger M; Erbes T
    Mol Diagn Ther; 2020 Apr; 24(2):215-232. PubMed ID: 32112368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary exosomal microRNA-96-5p and microRNA-183-5p expression as potential biomarkers of bladder cancer.
    El-Shal AS; Shalaby SM; Abouhashem SE; Elbary EHA; Azazy S; Rashad NM; Sarhan W
    Mol Biol Rep; 2021 May; 48(5):4361-4371. PubMed ID: 34085193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker.
    Erbes T; Hirschfeld M; Rücker G; Jaeger M; Boas J; Iborra S; Mayer S; Gitsch G; Stickeler E
    BMC Cancer; 2015 Mar; 15():193. PubMed ID: 25886191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of urinary exosomal microRNA-21 in the early diagnosis and prognosis of bladder cancer.
    Yang FK; Tian C; Zhou LX; Guan TY; Chen GL; Zheng YY; Cao ZG
    Kaohsiung J Med Sci; 2024 Jul; 40(7):660-670. PubMed ID: 38801488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel breast cancer screening: combined expression of miR-21 and MMP-1 in urinary exosomes detects 95% of breast cancer without metastasis.
    Ando W; Kikuchi K; Uematsu T; Yokomori H; Takaki T; Sogabe M; Kohgo Y; Otori K; Ishikawa S; Okazaki I
    Sci Rep; 2019 Sep; 9(1):13595. PubMed ID: 31537868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of potential serum and urine-based microRNA as minimally-invasive biomarkers for breast and gynecological cancer.
    Ritter A; Hirschfeld M; Berner K; Jaeger M; Grundner-Culemann F; Schlosser P; Asberger J; Weiss D; Noethling C; Mayer S; Erbes T
    Cancer Biomark; 2020; 27(2):225-242. PubMed ID: 32083575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A urinary microRNA (miR) signature for diagnosis of bladder cancer.
    Hofbauer SL; de Martino M; Lucca I; Haitel A; Susani M; Shariat SF; Klatte T
    Urol Oncol; 2018 Dec; 36(12):531.e1-531.e8. PubMed ID: 30322728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased urinary exosomal microRNAs in children with idiopathic nephrotic syndrome.
    Chen T; Wang C; Yu H; Ding M; Zhang C; Lu X; Zhang CY; Zhang C
    EBioMedicine; 2019 Jan; 39():552-561. PubMed ID: 30467011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary micro-RNA expressions and protein concentrations may differentiate bladder cancer patients from healthy controls.
    Güllü Amuran G; Tinay I; Filinte D; Ilgin C; Peker Eyüboğlu I; Akkiprik M
    Int Urol Nephrol; 2020 Mar; 52(3):461-468. PubMed ID: 31679136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
    Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
    Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Non-invasive Liquid Biopsy Screening of Urine-Derived Exosomes for miRNAs as Biomarkers in Endometrial Cancer Patients.
    Srivastava A; Moxley K; Ruskin R; Dhanasekaran DN; Zhao YD; Ramesh R
    AAPS J; 2018 Jul; 20(5):82. PubMed ID: 29987691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel panel of blood-based microRNAs capable of discrimination between benign breast disease and breast cancer at early stages.
    Sadeghi H; Kamal A; Ahmadi M; Najafi H; Sharifi Zarchi A; Haddad P; Shayestehpour B; Kamkar L; Salamati M; Geranpayeh L; Lashkari M; Totonchi M
    RNA Biol; 2021 Nov; 18(sup2):747-756. PubMed ID: 34793290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased serum miR-181a is a potential new tool for breast cancer screening.
    Guo LJ; Zhang QY
    Int J Mol Med; 2012 Sep; 30(3):680-6. PubMed ID: 22692639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of microRNAs derived from exosomes in bronchoalveolar lavage fluid of early-stage lung adenocarcinoma: A pilot study.
    Kim JE; Eom JS; Kim WY; Jo EJ; Mok J; Lee K; Kim KU; Park HK; Lee MK; Kim MH
    Thorac Cancer; 2018 Aug; 9(8):911-915. PubMed ID: 29806739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosome-transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression.
    Zheng R; Du M; Wang X; Xu W; Liang J; Wang W; Lv Q; Qin C; Chu H; Wang M; Yuan L; Qian J; Zhang Z
    Mol Cancer; 2018 Oct; 17(1):143. PubMed ID: 30285771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma.
    Zhang W; Ni M; Su Y; Wang H; Zhu S; Zhao A; Li G
    Eur Urol Focus; 2018 Apr; 4(3):412-419. PubMed ID: 28753793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and function exploration of microRNA-155 as a molecular biomarker for early detection of breast cancer.
    Liu X; Chang Q; Wang H; Qian H; Jiang Y
    Breast Cancer; 2021 Jul; 28(4):806-821. PubMed ID: 33475963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Situ Detection of Plasma Exosomal MicroRNA-1246 for Breast Cancer Diagnostics by a Au Nanoflare Probe.
    Zhai LY; Li MX; Pan WL; Chen Y; Li MM; Pang JX; Zheng L; Chen JX; Duan WJ
    ACS Appl Mater Interfaces; 2018 Nov; 10(46):39478-39486. PubMed ID: 30350935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-21-5p, miR-141-3p, and miR-205-5p levels in urine-promising biomarkers for the identification of prostate and bladder cancer.
    Ghorbanmehr N; Gharbi S; Korsching E; Tavallaei M; Einollahi B; Mowla SJ
    Prostate; 2019 Jan; 79(1):88-95. PubMed ID: 30194772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative functional genetic-epigenetic approach for selecting genes as urine biomarkers for bladder cancer diagnosis.
    Eissa S; Matboli M; Essawy NO; Kotb YM
    Tumour Biol; 2015 Dec; 36(12):9545-52. PubMed ID: 26138586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.